Acetylsalicylic acid Completed Phase 2 Trials for Gastroduodenal Ulcerations Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01646814Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects